You are here

Press releases

02.07.2020

Barcelona, 2 July 2020 Life sciences and healthcare start-ups and companies in Catalonia managed to attract €112M of investment in 2019, a figure that has remained stable for four years in a row and is 3% higher than in 2018, according to the study presented today by Biocat, CataloniaBio & HealthTech and EY.

Both investors and experts believe this investment to be a...

05.05.2020

Barcelona, May 5, 2020. A total of 11 international projects have been chosen to participate in the 3rd edition of CRAASH Barcelona, the acceleration program Biocat organizes in collaboration with CIMIT (Boston), the most experienced health accelerator in the world, and EIT Health, the leading European health consortium. The 11 projects chosen to participate in...

27.03.2020

Barcelona, 27 March 2020.- Barcelona will once again host BIO-Europe Spring (BES), the European partnering congress that specializes in biotechnology and the pharmaceutical industry, which will take place in the city from March 22 to 24, 2021.

The event is organized by EBD Group, which has chosen Barcelona again to host the fair after ...

21.01.2020

 

 

 

 

Barcelona, January 21, 2020. Biocat has opened the call for applications to the second edition of CRAASH Barcelona, a 12-week acceleration program that helps research teams from European countries successfully launch innovation to market in the healthtech arena. The deadline for applications is 16 March in www.craashbarcelona.org.

CRAASH Barcelona is organized by Biocat in collaboration with...

19.11.2019

Barcelona, November 20, 2019. - The main Catalan research centers have a joint total of over 6,000 active participations in nearly 4,000 clinical trials. In 2017 alone, more than 1,000 trial participations began in Catalonia (one trial may have participations at two or more Catalan centers). If we compare this internationally, Catalonia would be ranked 16th in the world in number of trial participations and 7th in Europe.

 

...

21.10.2019

Barcelona, October 21, 2019.- Boehringer Ingelheim, one of the top 20 pharmaceutical companies in the world, has become a partner of Design Health Barcelona (d·HEALTH Barcelona), the postgraduate program promoted by Biocat to train future innovators and entrepreneurs in the healthcare sector.

Following the biodesign methodology created by Stanford University, the participants in d·HEALTH Barcelona experience a...